FDA Inspection 1122962 — Broekman Instituut B.V.
The FDA completed an inspection of Broekman Instituut B.V. on March 6, 2020 in Someren. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 6, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Someren (Netherlands)